BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 18593934)

  • 21. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
    Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Of Myc and Mnt.
    Hooker CW; Hurlin PJ
    J Cell Sci; 2006 Jan; 119(Pt 2):208-16. PubMed ID: 16410546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translocations involving c-myc and c-myc function.
    Boxer LM; Dang CV
    Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
    Soucek L; Jucker R; Panacchia L; Ricordy R; Tatò F; Nasi S
    Cancer Res; 2002 Jun; 62(12):3507-10. PubMed ID: 12067996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant transformation by overproduction of translation initiation factor eIF4G.
    Fukuchi-Shimogori T; Ishii I; Kashiwagi K; Mashiba H; Ekimoto H; Igarashi K
    Cancer Res; 1997 Nov; 57(22):5041-4. PubMed ID: 9371500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.
    Kime L; Wright SC
    Biochem J; 2003 Feb; 370(Pt 1):291-8. PubMed ID: 12418961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation.
    Murooka TT; Rahbar R; Fish EN
    Biochem Biophys Res Commun; 2009 Sep; 387(2):381-6. PubMed ID: 19607806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
    Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
    Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Max network: coordinated transcriptional regulation of cell growth and proliferation.
    Eisenman RN
    Harvey Lect; 2000-2001; 96():1-32. PubMed ID: 12200869
    [No Abstract]   [Full Text] [Related]  

  • 32. Ectopic expression of myc or myn down-regulates immunoglobulin transcription.
    Sigvardsson M; Johansson K; Larsson LG; Nilsson K; Leanderson T
    Leukemia; 1994 Jul; 8(7):1157-63. PubMed ID: 8035607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of murine Max (Myn) parallels the regulation of c-Myc in differentiating murine erythroleukemia cells.
    Dunn BK; Cogliati T; Cultraro CM; Bar-Ner M; Segal S
    Cell Growth Differ; 1994 Aug; 5(8):847-54. PubMed ID: 7986749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-MYC: evidence for multiple regulatory functions.
    Penn LJ; Laufer EM; Land H
    Semin Cancer Biol; 1990 Feb; 1(1):69-80. PubMed ID: 2133113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene.
    Kuschak TI; Kuschak BC; Taylor CL; Wright JA; Wiener F; Mai S
    Oncogene; 2002 Jan; 21(6):909-20. PubMed ID: 11840336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis.
    Lin CJ; Nasr Z; Premsrirut PK; Porco JA; Hippo Y; Lowe SW; Pelletier J
    Cell Rep; 2012 Apr; 1(4):325-33. PubMed ID: 22573234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Id2 is dispensable for myc-induced lymphomagenesis.
    Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
    Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
    van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
    Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific isoforms of translation initiation factor 4GI show differences in translational activity.
    Coldwell MJ; Morley SJ
    Mol Cell Biol; 2006 Nov; 26(22):8448-60. PubMed ID: 16982693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of c-myc in cellular growth control.
    Schmidt EV
    Oncogene; 1999 May; 18(19):2988-96. PubMed ID: 10378694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.